In normal breast tissue or cell lines, ppGalNAc-T4 expression might provide a basic but necessary function to maintain regular physiological activities, while in the carcinoma environment, ppGalNAc-T4 may act as a cancer inhibitor by modifying certain specific substrate proteins, such as TβR II, in this study. This evidence concerns the gene CD4 and carcinoma.